home All News open_in_new Full Article

PharmaCorp Announces Executive Transition and New Director of Business Development

SASKATOON, Saskatchewan, Nov. 28, 2025 (GLOBE NEWSWIRE) — PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) today announced an executive transition in which Paul Dale has been appointed President and Chief Operating Officer, effective December 1, 2025, as Calvin LeRoux steps aside from the President role and assumes a one-year appointment as Strategic Advisor […]


today 6 d. ago attach_file Economics

attach_file Economics
attach_file Events
attach_file Economics
attach_file Politics
attach_file Politics
attach_file Economics
attach_file Economics


ID: 582407266
Add Watch Country

arrow_drop_down